Cargando…

Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette‐based survey

BACKGROUND: Anticoagulant treatment of splanchnic (SVT) and cerebral vein thrombosis (CVT) can be challenging due to the rarity of these conditions, the concomitantly high thrombotic and bleeding risks, and the available low‐quality evidence. OBJECTIVES: To explore the current therapeutic approaches...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riva, Nicoletta, Carrier, Marc, Gatt, Alex, Ageno, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles ‐ Thrombosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590282/ https://www.ncbi.nlm.nih.gov/pubmed/33134784 http://dx.doi.org/10.1002/rth2.12424

Ejemplares similares

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
por: Candeloro, Matteo, et al.
Publicado: (2022)

Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions
por: Riva, Nicoletta, et al.
Publicado: (2020)

Splanchnic Vein Thrombosis: Current Perspectives
por: Valeriani, Emanuele, et al.
Publicado: (2019)

Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A national survey and case-vignette study
por: Sissingh, Noor J, et al.
Publicado: (2023)

Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark
por: Klok, Frederikus A., et al.
Publicado: (2020)

Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis
por: Senzolo, Marco, et al.
Publicado: (2018)

Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study
por: Ageno, Walter, et al.
Publicado: (2022)

Post‐thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus study
por: de Kleijn, Robert J. C. M. F., et al.
Publicado: (2022)

Effect of anticoagulants on fibrin clot structure: A comparison between vitamin K antagonists and factor Xa inhibitors
por: Gauer, Julia S., et al.
Publicado: (2020)

Detection of upper extremity deep vein thrombosis by magnetic resonance non‐contrast thrombus imaging
por: van Dam, Lisette F., et al.
Publicado: (2021)

Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review
por: Moik, Florian, et al.
Publicado: (2021)

Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE
por: Cohen, Omri, et al.
Publicado: (2021)

Management of anticoagulation for cancer‐associated thrombosis in patients with thrombocytopenia: A systematic review
por: Samuelson Bannow, Bethany R., et al.
Publicado: (2018)

An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta‐analysis
por: Forgo, Gabor, et al.
Publicado: (2021)

Management of splanchnic vein thrombosis
por: Elkrief, Laure, et al.
Publicado: (2023)

Safety of using the combination of the Wells rule and D‐dimer test for excluding acute recurrent ipsilateral deep vein thrombosis
por: van Dam, Lisette F., et al.
Publicado: (2020)

Impaired factor V–related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations
por: Shimonishi, Naruto, et al.
Publicado: (2023)

Validation and psychometric properties of the Maltese version of the Duke Anticoagulation Satisfaction Scale (DASS)
por: Riva, Nicoletta, et al.
Publicado: (2019)

Reliability and validity of the Maltese version of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q)
por: Riva, Nicoletta, et al.
Publicado: (2019)

Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art
por: Monaco, Giovanni, et al.
Publicado: (2023)

Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction
por: Nagler, Michael, et al.
Publicado: (2018)

Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary “Real Life” Experience
por: Rupoli, Serena, et al.
Publicado: (2021)

Deep Vein Thrombosis after COVID-19 Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2021)

Thrombocytopenia with and without Thrombosis Following COVID-19 Vaccination
por: Ge, Melissa, et al.
Publicado: (2021)

Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
por: Potere, Nicola, et al.
Publicado: (2022)

Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis
por: Levy, Jerrold H., et al.
Publicado: (2020)

Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study
por: Jordan Bruno, Ximena, et al.
Publicado: (2022)

Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study
por: Riva, Nicoletta, et al.
Publicado: (2015)

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)

Timing of anticoagulation for the management of portal vein thrombosis in liver cirrhosis
por: Valeriani, Emanuele, et al.
Publicado: (2023)

Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD‐AF registry
por: Seelig, Jaap, et al.
Publicado: (2020)

Splanchnic Vein Thrombosis in the Mediterranean Area in Children
por: El-Karaksy, Hanaa, et al.
Publicado: (2011)

Splanchnic Vein Thrombosis: Etiology, Diagnosis, and Treatment
por: Qi, Xingshun, et al.
Publicado: (2015)

Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis
por: Camerlo, Sofia, et al.
Publicado: (2023)

Idiopathic splanchnic vein thrombosis: is it really idiopathic?
por: Barosi, Giovanni
Publicado: (2022)

Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
por: Lee, Jeffrey, et al.
Publicado: (2022)

Procoagulant factor levels and risk of venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2020)

Cancer-Associated Abdominal Vein Thrombosis
por: Muscat-Baron, Lorna, et al.
Publicado: (2023)

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
por: Warrior, Surbhi, et al.
Publicado: (2020)

Model‐dependent contributions of FXII and FXI to venous thrombosis in mice
por: Grover, Steven P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebcc9kidjg994af36vplci2tug